Antibiotic resistance has been of increasing concern to health professionals, with the potential for millions of extra deaths worldwide. In this session, the ABR WP presents the conclusions of its two-year study.  The presentation covers a medical/biological overview, ABR modelling considerations, our results (including comparisons v HIV and insurer cat risk stresses), and an introduction to the model (available through the IFOA website). The conclusions will be of interest from both mortality and longevity perspectives.  Presentation would be similar to the 25 Feb sessional paper event (Edinburgh). 

Speakers: Matthew Edwards, Willis Towers Watson and Nicola Oliver, Medical Intelligence